Freeze drying (lyophilization) is a highly effective preservation method designed to enhance the stability, transportability, and shelf life of sensitive pharmaceuticals. Despite its advantages, not all formulations are suitable for freeze drying. Many compounds fail because they cannot withstand freezing, sublimation, or dehydration stresses, or because their excipients and structural components behave unpredictably during the process. Understanding why certain formulations cannot be lyophilized is essential when designing stable drug products and selecting appropriate manufacturing technologies.
Some formulations cannot be freeze dried because the active ingredients degrade during freezing or dehydration, excipients crystallize or shift pH, the structure collapses during drying, or the final product cannot regain its original properties during reconstitution. These issues make freeze drying ineffective or lead to unacceptable product quality.
Introduction
Pharmaceutical freeze drying removes water through controlled freezing, primary drying (sublimation), and secondary drying (bound-water removal). While this process works for a broad range of biologics and injectables, certain formulations show irreversible structural damage, chemical instability, or physical collapse. These failures arise from incompatibilities between formulation components and the stresses applied during the freeze-drying cycle. Evaluating these risks early helps determine whether lyophilization is feasible or if alternative stabilization methods are needed.
Detailed Description
Instability of Active Ingredients During Freezing
Freezing generates ice crystals that exclude solutes and dramatically increase local solute concentration. Sensitive molecules—especially proteins, peptides, enzymes, and viral vectors—may lose structural integrity under these conditions. The resulting stresses include:
-
Denaturation due to solute concentration
-
Aggregation at the ice–liquid interface
-
Structural collapse or unfolding from low-temperature stress
If the active ingredient cannot tolerate freezing, the freeze-drying process becomes unsuitable regardless of cycle design.
Degradation Triggered by Drying and Dehydration
Secondary drying removes bound water molecules that help maintain molecular stability. Removing too much bound water can:
-
Disrupt hydrogen bonding networks
-
Increase molecular mobility
-
Accelerate degradation reactions
-
Cause loss of biologic activity
Some molecules require a minimum hydration level to maintain structure. These products degrade when fully dehydrated, making lyophilization impossible.
Incompatible Excipients and Buffer Systems
Excipients play a critical role in freeze-drying feasibility. Certain buffers and salts can destabilize formulations during freezing and drying:
-
Phosphate buffers may undergo significant pH shifts as components crystallize at different temperatures.
-
High salt content can intensify freeze-concentration stress and trigger irreversible denaturation.
-
Bulking agents may crystallize instead of forming an amorphous, protective matrix, causing poor cake structure.
If excipient combinations cannot provide cryo- or lyoprotection, the formulation cannot survive freeze drying.
Phase Separation and High-Viscosity Formulations
Highly concentrated or viscous solutions tend to freeze unevenly. Problems include:
-
Non-uniform ice crystal formation
-
Phase separation during freezing
-
Solute precipitation
-
Incomplete sublimation and high residual moisture
-
Structural collapse or shrinking of the cake
These issues lead to inconsistent drying, poor appearance, and instability during storage.
Complex Delivery Systems That Cannot Freeze Dry Properly
Certain modern delivery systems exhibit instability during freezing or sublimation. These include:
-
Liposomes
-
Nanoparticles
-
Emulsions
-
Micelles
-
Polymer-based delivery carriers
Freeze-related stress can rupture membranes, destabilize particle size distribution, or cause irreversible aggregation, making the final product unusable.
Poor Cake Formation or Reconstitution Performance
Even if dehydration is achieved, some formulations fail due to final product characteristics:
-
Collapsed or glassy cakes lacking porosity
-
Brittle cakes that powder or fragment
-
Slow or incomplete reconstitution due to matrix densification
-
Aggregation during rehydration, particularly in biologics
If the reconstituted product cannot perform as required, freeze drying is not a viable preservation method.
Regulatory and Economic Limitations
Some formulations could be adapted for freeze drying, but the effort is not justified due to:
-
Excessive cycle development cost
-
High equipment and energy requirements
-
Need for specialized excipients not approved for the product category
-
Availability of simpler stabilization methods, such as refrigerated liquid formulations
When practical or cost constraints outweigh the benefits, manufacturers may avoid lyophilization entirely.
Summary
Not every formulation is suitable for freeze drying. The limitations typically arise from instability during freezing or dehydration, incompatibility of excipients, high viscosity or complex compositions, unacceptable cake formation, and reconstitution issues. In some cases, economic or regulatory factors further discourage the use of lyophilization. Evaluating formulation behavior early—combined with robust thermal analysis and excipient screening—ensures that only suitable candidates proceed to freeze-drying process development.
Contact Us for Freeze Dryer and Lyophilization Support
Zhejiang Leadtop Pharmaceutical Machinery Co., Ltd (LTPM CHINA) provides:
-
Customized GMP freeze dryers for pharmaceutical and biotech production
-
Full-cycle lyophilization line integration and turnkey solutions
-
Professional support for thermal analysis, cycle development, and moisture control
-
Five-year warranty and global service for customers in Europe and America
Contact us today for expert consultation or equipment quotations.